Rezolute, Inc.

XNASHealth care

Last traded price · USD

$4.01

+1.27%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:40 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $3.96
Volume: 42
Day's high: —
Day's low: —

In brief

Rezolute, Inc. is a health care company listed on Nasdaq, valued at about $388M.
Its shares closed at $3.96 on 4 Nov 2026, down 55.5% over the past year.
From India you can buy RZLT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Rezolute, Inc. (RZLT) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole RZLT share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade RZLT options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −8.3% (SPY −1.6%, XLV +13.5%). 3 months: −15.4% (SPY −0.4%, XLV +15.5%). 1 year: −55.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: RZLT, SPY and XLV · as of 4 Nov 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $3.96 was 5.5% below its 50-day average ($4.19) and 1.4% above its 200-day average ($3.91). It has closed above the 200-day for 2 sessions, since 3 Nov 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
10.1 days to cover short interest
19.2M shares were sold short at the 15 Oct 2026 settlement, 19.8% of the 96.7M shares outstanding; covering them would take 10.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
28% of the way up its 52-week range
Closed at $3.96 on 4 Nov 2026: 65.4% below the 52-week high of $11.46 (10 Nov 2025) and 270.1% above the low of $1.07 (11 Dec 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−8.3%

6 months+26.1%

1 year−55.5%

5 years−40.0%

Newswire

About

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Website

Notable moves

December 12, 2025
+28.57%
December 11, 2025
−87.20%
March 18, 2022
+52.42%

Rezolute, Inc.

XNASHealth care

Last traded price · USD

$4.01

+1.27%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:40 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $3.96
Volume: 42
Day's high: —
Day's low: —

In brief

Rezolute, Inc. is a health care company listed on Nasdaq, valued at about $388M.
Its shares closed at $3.96 on 4 Nov 2026, down 55.5% over the past year.
From India you can buy RZLT in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Rezolute, Inc. (RZLT) shares from India?

Do I need the price of a whole RZLT share to invest?

How much can I invest in US stocks in a year?

Can I trade RZLT options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −8.3% (SPY −1.6%, XLV +13.5%). 3 months: −15.4% (SPY −0.4%, XLV +15.5%). 1 year: −55.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: RZLT, SPY and XLV · as of 4 Nov 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $3.96 was 5.5% below its 50-day average ($4.19) and 1.4% above its 200-day average ($3.91). It has closed above the 200-day for 2 sessions, since 3 Nov 2026. The 50-day average crossed above the 200-day on 7 Aug 2026, 62 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
10.1 days to cover short interest
19.2M shares were sold short at the 15 Oct 2026 settlement, 19.8% of the 96.7M shares outstanding; covering them would take 10.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
28% of the way up its 52-week range
Closed at $3.96 on 4 Nov 2026: 65.4% below the 52-week high of $11.46 (10 Nov 2025) and 270.1% above the low of $1.07 (11 Dec 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−8.3%

6 months+26.1%

1 year−55.5%

5 years−40.0%

Newswire

About

Website

Notable moves

December 12, 2025
+28.57%
December 11, 2025
−87.20%
March 18, 2022
+52.42%

Rezolute, Inc.

Rezolute, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

10.1 days to cover short interest

28% of the way up its 52-week range

Rezolute, Inc.

Rezolute, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

10.1 days to cover short interest

28% of the way up its 52-week range